Brief: Trinity Biotech Secures Regulatory Approval For Commencement Of Upstream Manufacturing Activities Of Uni-Gold™ HIV Rapid Test
10/02/2026 18:50
Feb 10 (Reuters) - Trinity Biotech PLC TRIB.O: TRINITY BIOTECH SECURES REGULATORY APPROVAL FOR COMMENCEMENT OF UPSTREAM MANUFACTURING ACTIVITIES OF UNI-GOLD™ HIV RAPID TEST UNDER ITS OFFSHORED AND OUTSOURCED MODEL, SUPPORTING FINANCIAL PERFORMANCE TRANSFORMATION Source text: ID:nGNX4TzkBq Further company coverage: TRIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM